publication venue for
- Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. 27:3S-24S. 2023
- Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics. 27:75-76. 2023
- Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies. 26:3S-23S. 2022
- Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers. 26:267-273. 2022
- Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns. 25:169-176. 2021
- The Role of IL-17 in Papulopustular Rosacea and Future Directions. 23:635-641. 2019
- Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma. 19:239-248. 2015
- Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma. 19:249-259. 2015
- Public Engagement with Dermatology Contents on Facebook. 19:304-308. 2015
- Think beyond the Skin. 19:22-27. 2015
- Clinical features of external genital warts.. 17 Suppl 2:S55-S60. 2013
- Managing external genital warts: practical aspects of treatment and prevention.. 17 Suppl 2:S68-S75. 2013
- Therapeutic options for external genital warts.. 17 Suppl 2:S61-S67. 2013
- Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus.. 17 Suppl 2:S47-S54. 2013
- One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population. 17:129-138. 2013
- Canadian Guidelines for the Management of Plaque Psoriasis: Overview. 15:210-219. 2011
- Drug-Induced Lichenoid Dermatitis with Histopathologic Features of Mycosis Fungoides in a Patient with Psoriasis. 14:307-309. 2010
- Development and Validation of a Scale for Acne Scar Severity (SCAR-S) of the Face and Trunk. 14:156-160. 2010
- Efficacy Outcomes in Patients Using Alefacept in the AWARE Study. 13:S122-S130. 2009
- Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies. 13:S58-S66. 2009
- Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics. 12:282-287. 2008
- Are All Seborrheic Keratoses Benign? Review of the Typical Lesion and Its Variants. 12:203-210. 2008
- Development and Validation of a Comprehensive Acne Severity Scale. 11:211-216. 2007
- Multitherapy Approach to Onychomycosis Therapy. 10:S44-S47. 2006
- Prevalence and Epidemiology of Onychomycosis. 10:S28-S33. 2006
- Teaching Dermatology to Canadian Undergraduate Medical Students 2011